Robert Kasirer is a real estate professional with an extensive background in senior healthcare and housing for individuals with disabilities. A long-time supporter of medical research at the UCLA Longevity Center (formerly the UCLA Center on Aging), Robert Kasirer has lent his financial support to research some of the most serious medical conditions affecting older Americans.
Even though it is the sixth-leading cause of death in Americans, Alzheimer’s has largely remained an enigma since its first reports over a century ago. However, recent studies from UCLA and Buck Institute researchers may point to major treatment pathways for the disease. Out of 10 participants in the clinical trial, nine exhibited subjective or objective improvements within six months through a comprehensive 36-point therapeutic program. Through a combination of lifestyle changes, medication, and brain stimulation exercises, the study was developed as an alternative to clinical drug trials, most of which have failed to produce meaningful results. Currently, there are five FDA-approved drugs to provide short-term relief from common symptoms, though none treat the underlying causes. The study is the first of its kind to exhibit a reversal of memory loss associated with Alzheimer’s disease, as well one of the first to utilize a combination therapy approach similar to those developed for heart disease, HIV, and cancer.